Possible use of the mucolytic drug, bromhexine hydrochloride, as a prophylactic agent against SARS-CoV-2 infection based on its action on the Transmembrane Serine Protease 2

Detalles Bibliográficos
Autores principales: Habtemariam, Solomon, Nabavi, Seyed Fazel, Ghavami, Saeid, Cismaru, Cosmin Andrei, Berindan-Neagoe, Ioana, Nabavi, Seyed Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192109/
https://www.ncbi.nlm.nih.gov/pubmed/32360584
http://dx.doi.org/10.1016/j.phrs.2020.104853

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192109/
https://www.ncbi.nlm.nih.gov/pubmed/32360584
http://dx.doi.org/10.1016/j.phrs.2020.104853

Ejemplares similares